Recombinant Human HIF-1 alpha/HIF1A protein (His Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
N-His
Activity
not tested
Cat no : Eg0939
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human HIF-1 alpha protein Arg575-Asn826 (Accession# Q16665-1) with a His tag at the N-terminus. |
GeneID | 3091 |
Accession | Q16665-1 |
PredictedSize | 28.3 kDa |
SDS-PAGE | 34-60 kDa, reducing (R) condition |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
HIF1a, the major regulator of the cellular responses to hypoxia, consists of an oxygen-sensitive subunit, HIF1 alpha (HIF1A), and an oxygen-insensitive subunit, HIF1 beta (arylhydrocarbon receptor nuclear transporter [ARNT]). Under normal oxygen conditions, HIF1a is continuously produced and destroyed, in a process involving hydroxylation, interaction with von Hippel-Lindau (VHL) protein, polyubiquitylation and subsequent proteasomal degradation. Under hypoxic conditions, hydroxylation is impaired and HIF1a is stabilized. HIF1a localizes in cytoplasm in normoxia, but it can translocate into nuclear in response to hypoxia.
References:
1.J E Albina, et al. (2001) Am J Physiol Cell Physiol. 281 (6):C1971-7. 2.Wang GL, et al. (1995) Proc Natl Acad Sci U S A.92 (12):5510-4. 3.Kubis HP, et al. (2005) Biochim Biophys Acta. 1745 (2):187-95.